Acticam
meloxicam
Table of contents
Overview
This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.
This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).
Authorisation details
Product details | |
---|---|
Name |
Acticam
|
Agency product number |
EMEA/V/C/000138
|
Active substance |
meloxicam
|
International non-proprietary name (INN) or common name |
meloxicam
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QM01AC06
|
Generic |
This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines. |
Publication details | |
---|---|
Marketing-authorisation holder |
Ecuphar
|
Revision |
8
|
Date of issue of marketing authorisation valid throughout the European Union |
09/12/2008
|
Contact address |
Product information
24/04/2020 Acticam - EMEA/V/C/000138 - IAIN-0023
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Therapeutic indication
Oral suspension:
Dogs:
Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.
Solution for injection:
Dogs:
Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.
Reduction of postoperative pain and inflammation following orthopaedic and soft-tissue surgery.
Cats:
Reduction of postoperative pain after ovariohysterectomy and minor soft-tissue surgery.